Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr;16(3):80-8.
doi: 10.1016/j.tcm.2006.01.003.

Vascular targeting: recent advances and therapeutic perspectives

Amin Hajitou  1 , Renata Pasqualini, Wadih Arap
Affiliations
Review

Vascular targeting: recent advances and therapeutic perspectives

Amin Hajitou et al. Trends Cardiovasc Med. 2006 Apr.

Abstract

The ability to deliver therapeutics site-specifically in vivo -- remains a major challenge for the treatment of malignant, inflammatory, cardiovascular, and degenerative diseases. The need to target agents safely, efficiently, and selectively has become increasingly evident because of progress in vascular targeting. The vascular endothelium is a central target for intervention, given its multiple roles in the physiology (in health) and pathophysiology (in disease) and its direct accessibility to circulating ligands. In cancer, the expression of specific molecules on the surface of vascular endothelial and perivascular cells might enable direct therapeutic targeting. The use of in vivo phage display has significantly contributed to the identification of such targets, which have been successfully used for directed vascular targeting in preclinical animal models. Several animal studies have been performed by using fused molecules between tumor endothelium-directed molecules and immunomodulatory, procoagulant, or cytotoxic molecules. In addition to delivery of therapeutic agents, vascular targeted gene therapies based on both ligand-directed delivery of gene vectors to tumor endothelium and transcriptional targeting have also emerged. In this review, we discuss ligand-directed vascular targeting strategies with an emphasis on recent developments related to phage-display-based screenings.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adams GP. Improving the tumor specificity and retention of antibody-based molecules. In Vivo. 1998;12:11–21. - PubMed
    1. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 1998;279:377–380. - PubMed
    1. Arap W, Kolonin M, Trepel M. Steps toward mapping the human vasculature by phage display. Nat Med. 2002;8:121–127. - PubMed
    1. Arap MA, Lahdenranta J, Mintz PJ. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell. 2004;6:275–284. - PubMed
    1. Barbas CF, Burton DR, Scott JK. Cold Spring Harbor Press; New York: 2000. Phage Display: a Laboratory Manual.

LinkOut - more resources

-